bachelor's at Medicina from Fundação Bahiana para o Desenvolvimento da Medicina (1989), master's at Paediatrics from Universidade de São Paulo (1997) and doctorate at Paediatrics from Universidade de São Paulo (2001). He is currently revisor at Lupus Foundation of American. Has experience in Medicine, acting on the following subjects: lúpus eritematoso sistêmico, adolescent, criança, juvenile systemic lupus erythematosus and systemic lupus erythematosus. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Daños colaterales |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
No drug treatment is completely free of risk and lack of response, adverse events and poor adherence may affect its effectiveness. There is also a large inter-individual variability in response to treatments with regard to efficacy and toxicity, and for many drugs, there is also a period of weeks to months to establish its efficacy. Within this context, this project aims to evaluate the i…
Juvenile idiopathic arthritis (JIA) is a group of diseases characterized by arthritis of unknown origin with onset before 16 years of age, the most common chronic rheumatic disease in childhood . Treatment with drugs modifying the course of disease, particularly methotrexate (MTX) and biological agents is allowing better prognosis and raises issues related to gonadal function in young pat…
Systemic lupus erythematosus (SLE) is an autoimmune disease of connective tissue, multisystemic. Behcet's syndrome (BS) and Takayasu's arteritis (TA) are inflammatory diseases of unknown etiology, classified as primary vasculitis, and may involve several organs. These three diseases affect women of reproductive age, which raises questions related to gonadal function in these patients. Wh…
(Only some records are available in English at this moment)
Saliva is suggested as an alternative matrix to individualize and optimize therapy in chronic diseases because of its non-invasive obtention, low complexity compared to conventional matrix and for offering, generally, a good correlation with the free drug in serum. However, few studies have explored the potential for monitoring drugs in this matrix, in part due to the low sensitivity of a…
No drug treatment is completely free of risk and lack of response, adverse events and poor adherence may affect its effectiveness. There is also a large inter-individual variability in response to treatments with regard to efficacy and toxicity, and for many drugs, there is also a period of weeks to months to establish its efficacy. Within this context, this project aims to evaluate the i…
| 8 / 4 | Completed research grants |
| 4 / 2 | Completed scholarships in Brazil |
| 12 / 6 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID